|
 |
|
 |
||
 |
 |
 |
 |
 |
 |
The Breast Cancer Research Foundation was founded in 1993 by Evelyn H. Lauder as
an independent, not-for-profit 501(c) (3) organization dedicated to funding innovative
clinical and genetic research. A minimum of 85 cents of each dollar donated to the
Foundation goes directly to breast cancer research and awareness programs.
Since its inception, the Foundation has raised more than $125 million - over $25
million in fiscal year 2005 alone - to support clinical and genetic research at medical
institutions across the globe conducting the most advanced and promising breast
cancer research that will help lead to prevention and a cure in our lifetime. In
October 2005, the Foundation awarded over $22 million in new grants to 110
researchers across the United States and in Canada, Europe, Israel, and Latin
America.
The Foundation invests in the most brilliant minds in breast cancer. For example,
Harvard Medical School investigators announced in February 2006 that they have
created the first publicly available library of reliably expressible proteins of a human
disease, in this case for breast cancer. The scientists, whose work has been funded
generously by BCRF since 2001, have identified 1,300 genes potentially involved in
breast cancer development. Their achievement will allow researchers to track
cancer-causing proteins, with the goal of learning how to impede them. This will
radically improve breast cancer treatment and prevention and save the lives of
thousands of women and men. It adds to recent important discoveries, also
supported by BCRF, in the areas of targeted therapies for breast cancer and
nutritional prevention of cancer recurrence.
The Foundation has received the highest rating from Charity Navigator, four
stars,for five consecutive years, which means BCRF has outperformed over 98.7%
of more than 5,000 evaluated charities in efficiently managing finances.
And Money Magazine named BCRF one of America’s eight top charities